Prognostic factors in head and neck carcinomas;Prognosefactoren bei kopf-hals-karzinomen

HNO

Volumn 50, Issue 1, 2002, Pages 35-42

  Weber, A ^a   Tannapfel, A ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Head and neck cancer; Molecular biology; Prognosis; Squamous cell carcinoma

Indexed keywords

MOLECULAR MARKER; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CANCER MORTALITY; CANCER STAGING; CARCINOGENESIS; CELL CYCLE; CORRELATION ANALYSIS; HEAD AND NECK CARCINOMA; HUMAN; MOLECULAR BIOLOGY; ONCOGENE; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; GENETICS; HEAD AND NECK TUMOR; MORTALITY; PATHOLOGY; REVIEW; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; HUMANS; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036882427     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s106-002-8063-2     Document Type: Article

References (63)

1. Avall-Lundqvist EH, Silfversward C, Aspenblad U, Nilsson BR, Auer GU (1997) The impact of tumour angiogenesis, p53 overexpression and proliferative activity (MIB-1) on survival in sguamous cervical carcinoma. Eur J Cancer 33: 1799-1804
2. Bahar R, Kunishi M, Kayada Y, Yoshiga K (1997) CD44 variant 6 (CD44v6) expression as a progression marker in benign, premalignant and malignant oral epithelial tissues. Int J Oral Maxillofac Surg 26: 443-446
3. Bartsch H (2000) Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat Res 462: 255-279
4. Bartsch H, Rojas M, Alexandrov K, Risch A (1998) Impact of adduct determination on the assessment of cancer susceptibility. Recent Results Cancer Res 154: 86-96
5. Bentzen SM, Johannson LV, Overgaard J, Thames HD (1991) Clinical radiobiology of squamous carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 20: 1197-1206
6. Bhalang, Kafrawy AH, Miles DA (1999) Immumohistochemical study of the expression of human chorionic gonadotropin-beta in oral squamous cell carcinoma. Cancer 85: 757-762
7. Boring CC, Squires TS, Tong T (1992) Cancer statistics. CA Cancer J Clin 2: 19-38
8. Chang LY, Lin SC, Chang CS, Wang YK, Hu YC, Chang KW (1999) Telomerase activity and in situ telomerase RNA expression in oral carcinogenesis. J Oral Pathol Med 28:389-396
9. Currran AJ, Gullane PJ, Irish J, Macmillan C, Freeman J, Kamel-Reid S (2000) Telomerase activity is upregulated in laryngeal squamous cell carcinoma. Laryngoscope 110: 391-396
10. Dietz A, Rudat V, Conradt C et al. (2000) Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas. HNO 48: 655-664
11. Dijkema IM, Struikmans H, Dullens HF, Kal HB, van der Tweel I, Battermann JJ (2000) Influence of p53 and bcl-2 on proliferative activity and treatment outcome in head and neck cancer patients. Oral Oncol 36: 54-60
12. Fan GK, Fujieda S, Sunaga H, Tsuzuki H, Ito N, Saito H (1999) Expression of protein p27 is associated with progression and prognosis in laryngeal cancer. Laryngoscope 109: 815-820
13. Friedrich RE, Bartel-Friedrich S, Plambeck K, Bahlo M, Klapdor R (1997) P53 auto-antibodies in the sera of patients with oral squamous cell carcinoma. Anticancer Res 17: 3183-3184
14. Fogel S, Ahomadegbe JC, Barrois M et al. (1996) High incidence of p53 mutations in primary and metastatic head and neck tumors. Frequent protein overexpression in normal epithelium. Bull Cancer 83: 227-233
15. Fujieda S, Inuzuka M, Tanaka N et al. (1999) Expression of p27 is associated with Bax expression and spontaneous apoptosis in oral and oropharyngeal carcinoma. Int J Cancer 84: 315-320
16. Gallo O, Santucci M, Franchi A (1997) Cumulative prognostic value of p16/CDKN2 and p53 oncoprotein expression in premalignant laryngeal lesions. J. Natl Cancer Inst 89: 1161-1163
17. Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G (2000) c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival. Anticancer Res 20: 997-1004
18. Gonzalez-Moles MA, Caballero R, Rodriguez-Archilla A, Ruiz-Avila I, Bravo I (1996) Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity. Acta Stomatol Belg 93: 159-165
19. Gottschlich S, Folz BJ, Goeroegh T, Lippert BM, Maass JD, Werner JA (1999) A new prognostic indicator for head and neck cancer - p53 serum antibodies? Anticancer Res 19: 2703-2705
20. Griffin TW, Pajak TF, Gillespie BW (1984) Predicting the response of head and neck cancers to radiation therapy with a multivariate modelling system: an analysis of the RTOG head and neck registry. Int J Radiat Oncol Biol Phys 10: 481-487
21. Hedstrom J, Grenman R, Ramsay H et al. (1999) Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous cell carcinoma of the oral cavity and oropharynx. Int J Cancer 84: 525-528
22. Hirvikoski P, Kumpulainen E, Virtaniemi J et al. (1999) Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression. Eur J Cancer 35: 231-237
23. Homma A, Furuta Y, Oridate N et al. (1999) Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Clin Cancer Res 5: 801-806
24. Ikeguchi M, Unate H, Maeta M, Kaibara N (1999) Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium. Langenbecks Arch Surg 384: 550-555
25. Kantola S, Parikka M, Jokinen K, Hyrynkangs K, Soini Y, Alho OP, Salo P (2000) Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 83: 614-619
26. Keller W, Van Dyke DL, Worsham MJ (1996) Loss of 18q and and homozygosity for the DCC locus: Possible markers for clinically aggressive squamous cell carcinoma. Anitcancer Res 16: 2365-2372
27. Kuttan NA, Bhakthan NM (1997) Epidermal growth factor receptor (EGFR) in oral squamous cell carcinomas: overexpression, localization and therapeutic implications. Indian J Dent Res 8: 9-18
28. Li Z, Shimada Y, Uchida S et al. (2000) TGF-alpha as well as VEGF, PD-ECGF and bFGF contribute to angiogenesis of esophageal squamous cell carcinoma. Int J Oncol 17: 453-460
29. Lo Muzio L, Staibano S, Pannone G et al. (1999) Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res 19: 3817-3826
30. Ma L, Ronai A, Riede UN, Kohler G (1998) Clinical implications of screening p53 gene mutations in head and neck squamous cell carcinomas. J Cancer Res Clin Oncol 124: 389-396
31. Maass JD, Gottschlich S, Lippert BM, Niemann AM, Gorogh T, Werner JA (1996) Antibody formation to cellular p53 protein in patients with squamous cell carcinomas of the upper respiratory and digestive system. Laryngorhinootologie 75: 53-56
32. Mao L, El-Naggar A (1999) Molecular changes in the multistage pathogenesis of head and neck cancer. In: Srivastava S, Henson DE, Gazda A (eds) Molecular pathology of early cancer. IOS Press, Amsterdam Berlin Oxford Tokyo Washington, pp 189-205
33. Mineta H, Miura K, Suzuki et al. (1999) Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma. Cancer 85: 1011-101734.
34. Miyoshi Y, Tsukonoki K, Imaizumi T et al. (1999) Telomerase activity in oral cancer. Oral Oncol 35: 283-289
35. Morawski K, Gabriel A, Namyslowski G, Ziolkowsky A, Pietrawska V, Steplewska K (1999) Clinical application of proliferating cell nuclear antigen, oncoprotein p53 and tumor front grading analysis in patients operated on for laryngeal cancer. Eur Arch Otorhinolaryngol 256: 378-383
36. Nathan CA, Sanders K, Abreo FW, Nassar R, Glass J (2000) Correlation of p53 and the proto-oncogene elF4 E in larynx cancers: prognostic implications. Cancer Res 60: 35.999-36.004
37. Nawroz H, Koch W, Anker P (1996) Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med 2: 1033-1035
38. Ogawa T, Tsurusako Y, Kimura M et al. (1999) Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck. Acta Otolaryngol Suppl 540: 72-76
39. Papadimitrakopoulou V, Izzo S, Lippman SM (1997) Frequent inactivation p16INK4A in oral premalignant lesions. Oncogene 14: 1799-1803
40. Piffko J, Bankfalvi A, Tory K et al. (1998) Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas. Head Neck 20: 8-15
41. Rassam MB, al-Bashir NN, al-Salihi AR, Hammasch MH, al-Sammerai FT, al-Ubaidi MA, Waheed IN (1995) Heat-stable alkaline phosphatase. A putative tumor marker of head and neck squamous cell carcinoma. Acta Oncol 34: 49-52
42. Raybau R, Diogene H, Tetu B, Morency R, Fortin A, Monteil RA (1996) P53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 32: 143-149
43. Reed AL, Califano J, Cairns P (1996) High frequency of p16 (CDKN2/MTS-1/INK4 A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56: 3630-3633
44. Rikimaru K, Tadokora K, Yamamoto T, Enomoto S, Tsuchida N (1992) Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of the head and neck. Head Neck 14: 8-13
45. Rudat V, Dietz A, Schramm O, Conradt C, Maier H, Flentje M, Wannenmacher M (1999) Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck canceer after concomitant boost radiochemotherapy. Radiother Oncol 53: 119-125
46. Rudat V, Vanselow B, Wollensack P, Bettschneider C, Osman Ahmet S, Eble MJ, Dietz A (2000) Repeatability and prognostic impact of the pretreatment pO(2) histography inpatients with advanced head and neck cancer. Radiother Oncol 57: 31-37
47. Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, Demard F (1991) Characterization, quantification and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13: 132-139
48. Shin DM, Lee JS, Lippmann SM et al. (1996) P53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J. Natl Cancer Inst 88: 519-529
49. Sittel C, Ruiz S, Kvasnicka HM, Volling P, Jungehulsing M, Eckel HE (2000) Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity. Laryngorhinootologie 79: 86-92
50. Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG (2000) Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18: 2046-2052
51. Sobin LH, Wittekind CH (eds) (1997) UICC-TNM classification of malignant tumours, 5th edn. Wiley Liss, New York
52. Spiro RH, Huvos AG, Wong GY (1986) Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of mouth. Am J Surg 152: 345-350
53. Stoll C, Baretton G, Soost F, Terpe HJ, Domide P, Lohrs U (1999) Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas. Oral Oncol 35:484-489
54. Strong EW, Kasdorf H, Henk JM (1995) Squamous cell carcinoma of the head and neck. In: Hermanek P, Gospodarowicz MK, Henson DE, Hutter RVP, Sobin LH (eds) Prognostic factors in cancer, Springer, Berlin Heidelberg New York, pp 12-22
55. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH (2000) Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma. Am J Clin Oncol 23: 241-243
56. Tramonti G, Fredeghini M, Donadio C, Norpoth M, Annichiarico C, Bianchi R, Bianchi C (2000) Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA and TPS) in patients without evidence of neoplasia. Cancer Detect Prev 24: 86-90
57. Tsukifuji R, Tagawa K, Hatamochi A, Shinkai H (1999) Expression of matrix metalloproteinase-1, -2, and -3 in squamous cell carcinoma and actinic keratosis. Br J Cancer 80: 1087-1091
58. Valente G, Giusti U, Kerim S et al. (1999) High prognostic impact of growth fraction parameters in advanced stage laryngeal squamous cell carcinoma. Oncol Rep 6: 289-293
59. Watling DL, Gown AM, Coltera MD (1992) Overexpression of p53 in head and neck cancer. Head Neck 14: 437-444
60. Xie X, Clausen OP, De Angelis P, Boysen M (1999) The prognostic value of spontaneous apoptosis, bax, bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 86: 913-920
61. Yanagawa T, Harada H, Iwasa S et al. (2000) c-Abl expression in oral squamous cell carcinomas. Oral Oncol 36: 89-94
62. Yoshikazi T, Maruyama Y, Sato H, Furukawa M (2001) Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma. Int J Cancer 95: 44-50
63. Zhang L, Zhang W (1999) Telomerase hTR and hTRT gene expression in oral precancerous lesions and squamous cell carcinomas. Chin J Dent Res 2: 43-48